ITGAM and breast carcinoma: Consistently, we found Gr1+CD11b+Ly6G+ granulocytic myeloid cells (neutrophils) activated Th1/Th17 responses and antitumor immunity in the PCL scaffolds of immune-competent BALB/c mice bearing breast cancer tumors.